Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

doi:10.1084/jem.182.5.1461

This Article

	Full Text (PDF, 1093K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Udagawa, N.
	Articles by Kishimoto, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Udagawa, N.
	Articles by Kishimoto, T.


Social Bookmarking

	What's this?

ARTICLES

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

N Udagawa, N Takahashi, T Katagiri, T Tamura, S Wada, DM Findlay, TJ Martin, H Hirota, T Taga and T Kishimoto
Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

We reported that interleukin (IL) 6 alone cannot induce osteoclast formation in cocultures of mouse bone marrow and osteoblastic cells, but soluble IL-6 receptor (IL-6R) strikingly triggered osteoclast formation induced by IL-6. In this study, we examined the mechanism of osteoclast formation by IL-6 and related cytokines through the interaction between osteoblastic cells and osteoclast progenitors. When dexamethasone was added to the cocultures, IL-6 could stimulate osteoclast formation without the help of soluble IL-6R. Osteoblastic cells expressed a very low level of IL-6R mRNA, whereas fresh mouse spleen and bone marrow cells, both of which are considered to be osteoclast progenitors, constitutively expressed relatively high levels of IL-6R mRNA. Treatment of osteoblastic cells with dexamethasone induced a marked increase in the expression of IL-6R mRNA. By immunoblotting with antiphosphotyrosine antibody, IL-6 did not tyrosine- phosphorylate a protein with a molecular mass of 130 kD in osteoblastic cells but did so in dexamethasone-pretreated osteoblastic cells. Osteoblastic cells from transgenic mice constitutively expressing human IL-6R could support osteoclast development in the presence of human IL- 6 alone in cocultures with normal spleen cells. In contrast, osteoclast progenitors in spleen cells from transgenic mice overexpressing human IL-6R were not able to differentiate into osteoclasts in response to IL- 6 in cocultures with normal osteoblastic cells. These results clearly indicate that the ability of IL-6 to induce osteoclast differentiation depends on signal transduction mediated by IL-6R expressed on osteoblastic cells but not on osteoclast progenitors.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Datta, H K, Ng, W F, Walker, J A, Tuck, S P, Varanasi, S S (2008). The cell biology of bone metabolism. J. Clin. Pathol. 61: 577-587 [Abstract] [Full Text]
Yoshitake, F., Itoh, S., Narita, H., Ishihara, K., Ebisu, S. (2008). Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-{kappa}B Signaling Pathways. J. Biol. Chem. 283: 11535-11540 [Abstract] [Full Text]
Bustamante, M, Nogues, X, Mellibovsky, L, Agueda, L, Jurado, S, Caceres, E, Blanch, J, Carreras, R, Diez-Perez, A, Grinberg, D, Balcells, S (2007). Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur J Endocrinol 157: 677-684 [Abstract] [Full Text]
Lu, H.-K., Chou, H.-P., Li, C.-L., Wang, M.-Y., Wang, L.-F. (2007). Stimulation of Cells Derived from Nifedipine-induced Gingival Overgrowth with Porphyromonas gingivalis, Lipopolysaccharide, and Interleukin-1{beta}. JDR 86: 1100-1104 [Abstract] [Full Text]
Duplomb, L., Dagouassat, M., Jourdon, P., Heymann, D. (2007). Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation. Stem Cells 25: 544-552 [Abstract] [Full Text]
Ghosh-Choudhury, N., Singha, P. K., Woodruff, K., Clair, P. S., Bsoul, S., Werner, S. L., Choudhury, G. G. (2006). Concerted Action of Smad and CREB-binding Protein Regulates Bone Morphogenetic Protein-2-stimulated Osteoblastic Colony-stimulating Factor-1 Expression. J. Biol. Chem. 281: 20160-20170 [Abstract] [Full Text]
Maggio, M., Guralnik, J. M., Longo, D. L., Ferrucci, L. (2006). Interleukin-6 in aging and chronic disease: a magnificent pathway.. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61: 575-584 [Abstract] [Full Text]
Dovio, A., Perazzolo, L., Saba, L., Termine, A., Capobianco, M., Bertolotto, A., Angeli, A. (2006). High-dose glucocorticoids increase serum levels of soluble IL-6 receptor {alpha} and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.. Eur J Endocrinol 154: 745-751 [Abstract] [Full Text]
O'Brien, C. A., Jilka, R. L., Fu, Q., Stewart, S., Weinstein, R. S., Manolagas, S. C. (2005). IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am. J. Physiol. Endocrinol. Metab. 289: E784-E793 [Abstract] [Full Text]
Liu, X.-H., Kirschenbaum, A., Yao, S., Levine, A. C. (2005). Cross-Talk between the Interleukin-6 and Prostaglandin E2 Signaling Systems Results in Enhancement of Osteoclastogenesis through Effects on the Osteoprotegerin/Receptor Activator of Nuclear Factor-{kappa}B (RANK) Ligand/RANK System. Endocrinology 146: 1991-1998 [Abstract] [Full Text]
Dovio, A., Perazzolo, L., Osella, G., Ventura, M., Termine, A., Milano, E., Bertolotto, A., Angeli, A. (2004). Immediate Fall of Bone Formation and Transient Increase of Bone Resorption in the Course of High-Dose, Short-Term Glucocorticoid Therapy in Young Patients with Multiple Sclerosis. J. Clin. Endocrinol. Metab. 89: 4923-4928 [Abstract] [Full Text]
Lerner, U. H. (2004). NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION. CROBM 15: 64-81 [Abstract] [Full Text]
Shin, H.-I., Divieti, P., Sims, N. A., Kobayashi, T., Miao, D., Karaplis, A. C., Baron, R., Bringhurst, R., Kronenberg, H. M. (2004). gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro. Endocrinology 145: 1376-1385 [Abstract] [Full Text]
Ragab, A. A., Nalepka, J. L., Bi, Y., Greenfield, E. M. (2002). Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am. J. Physiol. Cell Physiol. 283: C679-C687 [Abstract] [Full Text]
Vermes, C., Jacobs, J. J., Zhang, J., Firneisz, G., Roebuck, K. A., Glant, T. T. (2002). Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts. J. Biol. Chem. 277: 16879-16887 [Abstract] [Full Text]
Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., Higashio, K., Quinn, J. M. W., Gillespie, M. T., Martin, T. J., Suda, T., Takahashi, N. (2001). Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-{kappa}B Ligand. Endocrinology 142: 3656-3662 [Abstract] [Full Text]
Forseni, M., Bagger-Sjoback, D., Hultcrantz, M. (2001). A Study of Inflammatory Mediators in the Human Tympanosclerotic Middle Ear. Arch Otolaryngol Head Neck Surg 127: 559-564 [Abstract] [Full Text]
Wada, S., Yasuda, S., Nagai, T., Maeda, T., Kitahama, S., Suda, S., Findlay, D. M., Iitaka, M., Katayama, S. (2001). Regulation of Calcitonin Receptor by Glucocorticoid in Human Osteoclast-Like Cells Prepared in Vitro Using Receptor Activator of Nuclear Factor-{{kappa}}B Ligand and Macrophage Colony-Stimulating Factor. Endocrinology 142: 1471-1478 [Abstract] [Full Text]
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., FULLER, G. M. (2001). The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15: 43-58 [Abstract] [Full Text]
Takami, M., Takahashi, N., Udagawa, N., Miyaura, C., Suda, K., Woo, J.-T., Martin, T. J., Nagai, K., Suda, T. (2000). Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor-{{kappa}}B Ligand and Osteoprotegerin in Osteoblasts. Endocrinology 141: 4711-4719 [Abstract] [Full Text]
Manolagas, S. C. (2000). Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis. Endocr. Rev. 21: 115-137 [Abstract] [Full Text]
Klouche, M., Bhakdi, S., Hemmes, M., Rose-John, S. (1999). Novel Path to Activation of Vascular Smooth Muscle Cells: Up-Regulation of gp130 Creates an Autocrine Activation Loop by IL-6 and Its Soluble Receptor. J. Immunol. 163: 4583-4589 [Abstract] [Full Text]
Oelzner, P., Franke, S., Muller, A., Hein, G., Stein, G. (1999). Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford) 38: 841-847 [Abstract] [Full Text]
O'Brien, C. A., Gubrij, I., Lin, S.-C., Saylors, R. L., Manolagas, S. C. (1999). STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-kappa B Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone. J. Biol. Chem. 274: 19301-19308 [Abstract] [Full Text]
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., Martin, T. J. (1999). Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families. Endocr. Rev. 20: 345-357 [Abstract] [Full Text]
Ogata, Y., Kukita, A., Kukita, T., Komine, M., Miyahara, A., Miyazaki, S., Kohashi, O. (1999). A Novel Role of IL-15 in the Development of Osteoclasts: Inability to Replace Its Activity with IL-2. J. Immunol. 162: 2754-2760 [Abstract] [Full Text]
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., Fuller, G. M. (1999). C-reactive Protein: A Physiological Activator of Interleukin 6�Receptor Shedding. JEM 189: 599-604 [Abstract] [Full Text]
Matsuzaki, K., Katayama, K., Takahashi, Y., Nakamura, I., Udagawa, N., Tsurukai, T., Nishinakamura, R., Toyama, Y., Yabe, Y., Hori, M., Takahashi, N., Suda, T. (1999). Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene. Endocrinology 140: 925-932 [Abstract] [Full Text]
Peters, M., Muller, A. M., Rose-John, S. (1998). Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis. Blood 92: 3495-3504 [Full Text]
Renne, C., Kallen, K.-J., Mullberg, J., Jostock, T., Grotzinger, J., Rose-John, S. (1998). A New Type of Cytokine Receptor Antagonist Directly Targeting gp130. J. Biol. Chem. 273: 27213-27219 [Abstract] [Full Text]
Ozbek, S., Grotzinger, J., Krebs, B., Fischer, M., Wollmer, A., Jostock, T., Mullberg, J., Rose-John, S. (1998). The Membrane Proximal Cytokine Receptor Domain of the Human Interleukin-6 Receptor Is Sufficient for Ligand Binding but Not for gp130 Association. J. Biol. Chem. 273: 21374-21379 [Abstract] [Full Text]
Kwon, B. S., Wang, S., Udagawa, N., Haridas, V., Lee, Z. H., Kim, K. K., Oh, K.-o., Greene, J., Li, Y., Su, J., Gentz, R., Aggarwal, B. B., Ni, J. (1998). TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J. 12: 845-854 [Abstract] [Full Text]
Pacifici, R. (1998). Editorial: Cytokines, Estrogen, and Postmenopausal Osteoporosis--The Second Decade. Endocrinology 139: 2659-2661 [Full Text]
Hill, P. A., Tumber, A., Papaioannou, S., Meikle, M. C. (1998). The Cellular Actions of Interleukin-11 on Bone Resorption in Vitro. Endocrinology 139: 1564-1572 [Abstract] [Full Text]
Liu, B.-Y., Guo, J., Lanske, B., Divieti, P., Kronenberg, H. M., Bringhurst, F. R. (1998). Conditionally Immortalized Murine Bone Marrow Stromal Cells Mediate Parathyroid Hormone-Dependent Osteoclastogenesis in Vitro. Endocrinology 139: 1952-1964 [Abstract] [Full Text]
Rubin, J., Biskobing, D. M., Jadhav, L., Fan, D., Nanes, M. S., Perkins, S., Fan, X. (1998). Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells. Endocrinology 139: 1006-1012 [Abstract] [Full Text]
Franchimont, N., Gangji, V., Durant, D., Canalis, E. (1997). Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts. Endocrinology 138: 5248-5255 [Abstract] [Full Text]
Schiller, C., Gruber, R., Redlich, K., Ho, G.-M., Katzgraber, F., Willheim, M., Pietschmann, P., Peterlik, M. (1997). 17{beta}-Estradiol Antagonizes Effects of 1{alpha},25-Dihydroxyvitamin D3 on Interleukin-6 Production and Osteoclast-Like Cell Formation in Mouse Bone Marrow Primary Cultures. Endocrinology 138: 4567-4571 [Abstract] [Full Text]
Kawasaki, K., Gao, Y.-H., Yokose, S., Kaji, Y., Nakamura, T., Suda, T., Yoshida, K., Taga, T., Kishimoto, T., Kataoka, H., Yuasa, T., Norimatsu, H., Yamaguchi, A. (1997). Osteoclasts Are Present in gp130-Deficient Mice. Endocrinology 138: 4959-4965 [Abstract] [Full Text]
Tsunenari, T., Koishihara, Y., Nakamura, A., Moriya, M., Ohkawa, H., Goto, H., Shimazaki, C., Nakagawa, M., Ohsugi, Y., Kishimoto, T., Akamatsu, K.-i. (1997). New Xenograft Model of Multiple Myeloma and Efficacy of a Humanized Antibody Against Human Interleukin-6 Receptor. Blood 90: 2437-2444 [Abstract] [Full Text]
Bellido, T., Borba, V. Z. C., Roberson, P., Manolagas, S. C. (1997). Activation of the Janus Kinase/STAT (Signal Transducer and Activator of Transcription) Signal Transduction Pathway by Interleukin-6-Type Cytokines Promotes Osteoblast Differentiation. Endocrinology 138: 3666-3676 [Abstract] [Full Text]
Tai, H., Miyaura, C., Pilbeam, C. C., Tamura, T., Ohsugi, Y., Koishihara, Y., Kubodera, N., Kawaguchi, H., Raisz, L. G., Suda, T. (1997). Transcriptional Induction of Cyclooxygenase-2 in Osteoblasts Is Involved in Interleukin-6-Induced Osteoclast Formation. Endocrinology 138: 2372-2379 [Abstract] [Full Text]
Franchimont, N., Rydziel, S., Delany, A. M., Canalis, E. (1997). Interleukin-6 and Its Soluble Receptor Cause a Marked Induction of Collagenase 3�Expression in Rat Osteoblast Cultures. J. Biol. Chem. 272: 12144-12150 [Abstract] [Full Text]
Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. �J., Gillespie, M. T. (1997). Interleukin-18 (Interferon-gamma -inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-gamma to Inhibit Osteoclast Formation. JEM 185: 1005-1012 [Abstract] [Full Text]
Wada, S., Udagawa, N., Akatsu, T., Nagata, N., Martin, T. J., Findlay, D. M. (1997). Regulation by Calcitonin and Glucocorticoids of Calcitonin Receptor Gene Expression in Mouse Osteoclasts. Endocrinology 138: 521-529 [Abstract] [Full Text]
Kimble, R. B., Srivastava, S., Ross, F. P., Matayoshi, A., Pacifici, R. (1996). Estrogen Deficiency Increases the Ability of Stromal Cells to Support Murine Osteoclastogenesis via an Interleukin-1and Tumor Necrosis Factor-mediated Stimulation of Macrophage Colony-stimulating Factor Production. J. Biol. Chem. 271: 28890-28897 [Abstract] [Full Text]